Tremendous Growth of ICU Automated External Defibrillators (AEDs) Market in 2020-2025


Posted September 1, 2020 by Rupali07

The report on Global ICU Automated External Defibrillators (AEDs) Market 2020 includes a study of annual and financial reports of top players, Market Share and Market Size.

 
The report on Global ICU Automated External Defibrillators (AEDs) Market 2020 includes a study of annual and financial reports of top players, Market Share and Market Size. This research report offers in-depth study of Key Players, Product and Regional Analysis over the forecast period (2020-2025).

Global ICU Automated External Defibrillators (AEDs) Market overview:

Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/262802 .

The in-hospital spread of automated external defibrillators (AEDs) is aimed to allow for a shock-delivery within three minutes. However, it has to be questioned if the implementation of AED alone really contributes to a ‘heart-safe hospital’. The Global ICU Automated External Defibrillators (AEDs) Market is segmented on the basis of Product Type, Application, End Use Industry and Region.

On the Basis of Product Type segment, the ICU Automated External Defibrillators (AEDs) Market is sub segmented into Semi-automated and Fully-automated. Based on End Use Industry segment, the ICU Automated External Defibrillators (AEDs) Market is sub segmented into Hospital and clinic.

Some of the ICU Automated External Defibrillators (AEDs) Market manufacturers involved in the market are Philips, ZOLL Medical Corporation, Physio-Control, Laerdal Medical, Medtronic, Abbott, Boston Scientific, Biotronik, Nihon Kohden, Schiller, HeartSine Technologies, A.M.I. Italia, Metrax GmbH, Instramed, Mindray, Beijing M&B Electronic, Shenzhen XFT in World, effective mergers are some of the strategies adopted by the ICU Automated External Defibrillators (AEDs) Market manufacturers. New product launches and continuous technological innovations are the ICU Automated External Defibrillators (AEDs) Market strategies adopted by the major players.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “ICU Automated External Defibrillators (AEDs) Market Report 2020” @ https://www.businessindustryreports.com/buy-now/262802/single .

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study.

There are several manufacturers of ICU Automated External Defibrillators (AEDs) in Europe and North America. In North America, the demand for ICU Automated External Defibrillators (AEDs) is primarily driven by the Healthcare sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/262802 .

Top Industry News:

ABBOTT RECEIVES FDA APPROVAL FOR NEW HEART RHYTHM DEVICES FEATURING BLUETOOTH CONNECTIVITY AND CONTINUOUS REMOTE MONITORING ON 06 JULY, 2020 -- Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices bring new benefits to patients with heart rhythm disorders, including a patient-preferred design without compromising battery longevity and MRI compatibility.  In addition, the new devices offer Bluetooth technology and a new patient smartphone app for improved remote monitoring, allowing for increased patient/physician engagement and streamlined communications.

It is estimated that as many as 6.1 million people in the United States battle cardiac arrhythmias, or abnormal heart rhythms, and ICDs are used to help reduce the risks of life-threatening arrhythmias. For patients with heart failure or in situations when the heart's chambers beat out of sync, CRT-Ds can be used to restore the heart's natural pattern of beating.

"We are focused on developing and delivering life-changing technologies that impact patient care in a meaningful way," said Randel Woodgrift, senior vice president, Cardiac Rhythm Management, Abbott. "The Gallant devices are the latest example of how Abbott is driving innovation to meet changing healthcare needs and helping to improve connectivity and engagement between patients and their doctors."

The new Gallant system pairs with Abbott's secure myMerlinPulse, an iOS- and Android compatible mobile smartphone app that helps streamline communication between doctors and their patients. The app provides people with access to data, device performance, and transmission history, which helps them take an active role in their healthcare. Through the myMerlinPulse app, physicians can continuously monitor their patients remotely allowing for identification of asymptomatic episodes as well as patient-triggered transmissions, which can lead to earlier intervention and reduce clinical burden.

"The ability for patients to stay connected to their doctors via their implanted device and a smartphone app has the potential to change how healthcare providers and patients communicate with each other," said Raffaele Corbisiero, M.D., FACC, director of electrophysiology and pacing at Deborah Heart and Lung Center, Browns Mills, N.J. "The FDA's approval of Abbott's Gallant devices enables doctors to provide a more collaborative approach to treatment plans and the increased bond between a patient and provider will lead to better outcomes for all."

Table of Contents:

1 ICU Automated External Defibrillators (AEDs) Product Definition
2 Global ICU Automated External Defibrillators (AEDs) Market Manufacturer Share and Market Overview
2.1 Global Manufacturer ICU Automated External Defibrillators (AEDs) Shipments
2.2 Global Manufacturer ICU Automated External Defibrillators (AEDs) Business Revenue
2.3 Global ICU Automated External Defibrillators (AEDs) Market Overview
3 Manufacturer ICU Automated External Defibrillators (AEDs) Business Introduction
3.1 Philips ICU Automated External Defibrillators (AEDs) Business Introduction
3.1.1 Philips ICU Automated External Defibrillators (AEDs) Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Philips ICU Automated External Defibrillators (AEDs) Business Distribution by Region
3.1.3 Philips Interview Record
3.1.4 Philips ICU Automated External Defibrillators (AEDs) Business Profile
3.1.5 Philips ICU Automated External Defibrillators (AEDs) Product Specification
3.2 ZOLL Medical Corporation ICU Automated External Defibrillators (AEDs) Business Introduction
3.2.1 ZOLL Medical Corporation ICU Automated External Defibrillators (AEDs) Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 ZOLL Medical Corporation ICU Automated External Defibrillators (AEDs) Business Distribution by Region
3.2.3 Interview Record
3.2.4 ZOLL Medical Corporation ICU Automated External Defibrillators (AEDs) Business Overview
3.2.5 ZOLL Medical Corporation ICU Automated External Defibrillators (AEDs) Product Specification
3.3 Physio-Control ICU Automated External Defibrillators (AEDs) Business Introduction
3.3.1 Physio-Control ICU Automated External Defibrillators (AEDs) Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Physio-Control ICU Automated External Defibrillators (AEDs) Business Distribution by Region
3.3.3 Interview Record
3.3.4 Physio-Control ICU Automated External Defibrillators (AEDs) Business Overview
3.3.5 Physio-Control ICU Automated External Defibrillators (AEDs) Product Specification
3.4 Laerdal Medical ICU Automated External Defibrillators (AEDs) Business Introduction
3.5 Medtronic ICU Automated External Defibrillators (AEDs) Business Introduction
3.6 Abbott ICU Automated External Defibrillators (AEDs) Business Introduction
………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

[email protected]

+19376349940
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Business Industry Reports
Phone 09376349940
Business Address Office No. 3, Renuka Apartment, Revenue Colony,
Near Sane Guruji School, Dandekar Bridge, Sinhgad Road
Country India
Categories Health , Medical , Services
Tags abbott , biotronik , boston scientific , global icu automated external defibrillators aeds market , icu automated external defibrillators aeds , icu automated external defibrillators aeds market , icu automated external defibrillators aeds market size , medtronic
Last Updated September 1, 2020